SMAD4 and prostate carcinoma: Likewise, a recent study showed that the overexpression of miR-888 increased cellular proliferation and migration by targeting the tumor suppressor genes RBL1 and SMAD4, suggesting the oncogenic role of miR-888 in prostate cancer progression (13).